The first total synthesis of (+)-squamotacin, 1, which has shown cytotoxic
selectivity for the human prostate tumor cell line, was; achieved in 27 ste
ps and 0.83% yield starting with (+)-muricatacin, 4. All asymmetric centers
in the bistetrahydrofuran fragment of the molecules were produced by the S
harpless asymmetric dihydroxylation (AD) and the asymmetric epoxidation (AE
) reactions.